FlaniganM.J., LimV.S.Initial treatment of dialysis associated peritonitis: A controlled trial of vancomycin versus cefazolin.Perit Dial Int1991; 11: 31–7.
4.
GucekA., BrenA.F., LindicJ., HergouthV., MlinsekD.Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?Adv Perit Dial1994; 10: 144–6.
5.
AlvesF.R., DantasR.C.Is the treatment of beta lactam sensitive infections without vancomycin possible (Abstract)?Perit Dial Int1997; 17(Suppl 1): S27.
6.
VasS., BargmanJ., OreopoulosD.G.Treatment in PD patients of peritonitis caused by gram-positive organism with single daily dose of antibiotics.Perit Dial Int1997; 17: 91–3.
7.
SandoeJ.A.T., GokalR., StruthersJ.K.Vancomycin-resistant enterococci and empirical vancomycin for CAPD peritonitis.Perit Dial Int1997; 17: 617–18.
8.
OnozatoM.L., CaramoriJ.C.T., BarrettiP.Initial treatment of CAPD peritonitis: Poor response with association of cefazolin and amikacin.Perit Dial Int1999; 19: 88–9.
9.
MasonN.A., ZhangT., MessanaJ.M.Methicillin resistance patterns associated with peritonitis in a university-based peritoneal dialysis center.Perit Dial Int1999; 19: 483–6.
TroidleL., KligerA.S., Gorban–BrennanN., FikrigM., GoldenM., FinkelsteinF.O.Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci.Kidney Int1996; 50: 1368–72.
13.
SchwalbeR.S., StapletonJ.T., GilliganP.H.Emergence of vancomycin resistance in coagulase-negative staphylococci.N Engl J Med1987; 316: 927–31.
14.
SanyalD., JohnsonA.P., GeorgeR.C., CooksonB.D., WilliamsA.J.Peritonitis due to vancomycin-resistant Staphylococcus epidermidis.Lancet1991; 337: 54.
15.
HiramatsuK., AritakaN., HanakiH., KawasakiS., HosodaY., HoriS.Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.Lancet1997; 350: 1670–3.
16.
SmithT.L., PearsonM.L., WilcoxK.R., CruzC., LancasterM.V., Robinson–DunnB.Emergence of vancomycin resistance in Staphylococcus aureus.N Engl J Med1999; 340: 493–501.
17.
SieradzkiK., RobertsR.B., HaberS.W., TomaszA.The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.N Engl J Med1999; 340: 517–23.
18.
RotunS.S., McMathV., SchoonmakerD.J., MaupinP.S., TenoverF.C., HillB.C.Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.Emerg Infect Dis1999; 5: 147–9.
19.
Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance (Published erratum appears in Infect Control Hosp Epidemiol 1995; 16: 498).Infect Control Hosp Epidemiol1995; 16: 105–13.
20.
MorrisJ.G., ShayD.K., HebdenJ.N., McCarterR.J., PerdueB.E., JarvisW.Enterococci resistant to multiple antimicrobial agents, including vancomycin: Establishment of endemicity in a university medical center.Ann Intern Med1995; 123: 250–9.
21.
BartlettJ.G., BradleyS.F., HerwaldtL.A.A roundtable discussion of antibiotic resistance: Putting the lessons to work.Am J Med1999; 106(5A): 48S–52S.
GendehB.S., GibbA.G., AzizN.S., KongN., ZahirZ.M.Vancomycin administration in continuous ambulatory peritoneal dialysis: The risk of ototoxicity.Otolaryngol Head Neck Surg1998; 118: 551–8.
